Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19
Clinical trial NCT04353518 · UNKNOWN
Trial details
- NCT number
- NCT04353518
- Sponsor
- Cadila Pharnmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-03-30
- Enrollment
- 4000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.